Drugs for Herpes Simplex (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 295)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Acyclovir |
Approved |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
59277-89-3 |
2022
|
Synonyms:
1pwy
2-Amino-1,9-dihydro-9-((2-hydroxyethoxy)methyl)-6H-purin-6-one
2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one
2-Amino-9-(2-hydroxy-ethoxymethyl)-1,9-dihydro-purin-6-one
2-amino-9-(2-hydroxyethoxymethyl)-3H-purin-6-one
2-Amino-9-[(2-hydroxyethoxy)methyl]-1,9-dihydro-6H-purin-6-one
2-amino-9-{[(2-hydroxyethyl)oxy]methyl}-1,9-dihydro-6H-purin-6-one
59277-89-3
6H-Purin-6-one,2-amino-1,9-dihydro-9-((2-hydroxyethoxy)mehtyl)
9-((2-Hydroxyethoxy)methyl)guanine
9-(2-Hydroxyethoxy)methylguanine
9-[(2-Hydroxyethoxy)- methyl]guanine
9-[(2-Hydroxyethoxy)methyl]guanine
9-[(2-Hydroxyethoxy)-methyl]guanine
9-Hyroxyethoxymethylguanine
9-HYROXYETHOXYMETHYLGUANINE
A 4669
A1562_SIGMA
A4669_SIGMA
abello Brand OF aciclovir
AC-11038
AC1L1CR6
AC2
Aci sanorania
Acic
Aciclobeta
Aciclostad
Aciclovier
Aciclovir
Aciclovir (JAN/INN)
Aciclovir abello brand
Aciclovir alcon brand
Aciclovir alonga
Aciclovir alphapharm brand
Aciclovir amrad brand
Aciclovir azupharma brand
Aciclovir betapharm brand
Aciclovir britisfarma brand
Aciclovir clonmel brand
Aciclovir CT-arzneimittel brand
Aciclovir dermapharm brand
Aciclovir fabrigen brand
Aciclovir fustery brand
Aciclovir grin brand
Aciclovir grünenthal brand
Aciclovir hexal brand
Aciclovir isis brand
Aciclovir kendrick brand
Aciclovir lichtenstein brand
Aciclovir liomont brand
Aciclovir mann brand
Aciclovir menarini brand
Aciclovir niddapharm brand
Aciclovir novag brand
Aciclovir novartis brand
Aciclovir pensa brand
Aciclovir pisa brand
Aciclovir rentschler brand
Aciclovir sanorania
Aciclovir sanorania brand
Aciclovir stada brand
Aciclovir tad brand
Aciclovir ursapharm brand
Aciclovir von CT
Aciclovir warner-lambert brand
Aciclovir wellcome brand
Aciclovir wolff brand
Aciclovir yamanouchi brand
Aciclovir zyma brand
Aciclovir, Acycloguanosine, Zovirax, Acyclovir
Aciclovir-sanorania
Aciclovirum
Aciclovirum [INN-Latin]
Aciclovirum [Latin]
Acifur
Acipen solutab
Aci-sanorania
Acivir
Activir
ACV & Pluronic F-68
acyclo V
AcycloFoam
Acycloguanosine
acyclo-V
acyclovir
Acyclovir
Acyclovir & Pluronic F-68
Acyclovir (USP)
Acyclovir [USAN]
Acyclovir Lauriad
Acyclovir sodium
Acyclovir-side chain-2-3H
AKOS000656213
Alcon brand OF aciclovir
Alonga brand OF aciclovir
Alonga brand OF aciclovir sodium salt
Alphapharm brand OF aciclovir
Alti-Acyclovir
Amrad brand OF aciclovir
Antiherpes creme
Avirax
Azupharma brand OF aciclovir
BAS 00485787
BB_NC-0569
Betapharm brand OF aciclovir
BIDD:GT0646
B-LF& ACV
Bovine lactoferrin & 2-Amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6H-purin-6-one
BPBio1_000014
Britisfarma brand OF aciclovir
Britisfarma brand OF aciclovir sodium salt
BSPBio_000012
BSPBio_003348
Bull brand OF aciclovir
BW-248U
BW-248-U
BW-248U74
C06810
C8H11N5O3
CAS-59277-89-3
CCRIS 1953
CHEBI:2453
CHEMBL184
Cicloferon
CID2022
Clonmel brand OF aciclovir
Clonorax
CPD000058225
CT Arzneimittel brand OF aciclovir
CT-Arzneimittel brand OF aciclovir
Curasan brand OF aciclovir sodium salt
Cusiviral
D00222
DB00787
Dermapharm brand OF aciclovir
DivK1c_000185
DRG-0008
|
EINECS 261-685-1
EU-0100037
Fabrigen brand OF aciclovir
FT-0082883
Fustery brand OF aciclovir
Genvir
glaxo Wellcome brand OF aciclovir
glaxo Wellcome brand OF aciclovir sodium salt
Grin brand OF aciclovir
Grünenthal brand OF aciclovir
Grünenthal brand OF aciclovir sodium salt
Hascovir
Herpetad
Herpofug
Herpotern
Herpoviric
Hexal brand OF aciclovir
Hexal brand OF aciclovir sodium salt
HMS1568A14
HMS1922E08
HMS2090G09
HMS500J07
HSDB 6511
I01-1122
IDI1_000185
InChI=1/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15
Isavir
Isis brand OF aciclovir
KBio1_000185
KBio2_002219
KBio2_004787
KBio2_007355
KBio3_002850
KBioGR_000889
KBioSS_002219
Kendrick brand OF aciclovir
Laciken
Lichtenstein brand OF aciclovir
Liomont brand OF aciclovir
Lopac0_000037
Lopac-A-4669
LS-127209
Mann brand OF aciclovir
Mapox
Maynar
Menarini brand OF aciclovir
Menarini brand OF aciclovir sodium salt
Milavir
MLS000069633
MolPort-000-768-994
MolPort-001-889-834
NCGC00015061-01
NCGC00015061-02
NCGC00015061-03
NCGC00015061-04
NCGC00015061-10
NCGC00022426-03
NCGC00093555-01
NCGC00093555-02
NCGC00093555-03
NCGC00093555-04
NCGC00167756-01
Niddapharm brand OF aciclovir
NINDS_000185
Novag brand OF aciclovir
Novartis brand OF aciclovir
NSC 645011
NSC645011
Opthavir
Parke davis brand OF aciclovir
Pensa brand OF aciclovir
Pensa brand OF aciclovir sodium salt
Pharma investi brand OF aciclovir
Pisa brand OF aciclovir
Prestwick_6
Prestwick0_000086
Prestwick1_000086
Prestwick2_000086
Prestwick3_000086
Rentschler brand OF aciclovir
Rentschler brand OF aciclovir sodium salt
S1807_Selleck
SAM002589967
Sanorania brand OF aciclovir
Sanorania brand OF aciclovir sodium salt
SMP1_000007
SMR000058225
Sodium, acyclovir
Solutab, acipen
SPBio_001466
SPBio_001951
Spectrum_001739
SPECTRUM1503603
Spectrum2_001563
Spectrum3_001874
Spectrum4_000225
Spectrum5_001093
Stada brand OF aciclovir
STK796771
Supraviran
TAD brand OF aciclovir
TL8003779
UNII-X4HES1O11F
Ursapharm brand OF aciclovir
Viclovir
Vipral
Virax puren
Virax-puren
ViraxPuren
Virherpes
Virmen
Virolex
Viropump
Virorax
Virupos
Virzin
W-248-U
Warner lambert brand OF aciclovir
Warner wellcome brand OF aciclovir
Warner-lambert brand OF aciclovir
Wellcome 248u
Wellcome brand OF aciclovir
Wellcome brand OF aciclovir sodium salt
Wellcome248u
Wellcome-248u
Wellcome-248U
Wolff brand OF aciclovir
Yamanouchi brand OF aciclovir
ZINC01530555
Zoliparin
Zovir
Zovirax
Zovirax (TN)
Zovirax for injection
Zovirax Oral Acyclovir (ACV) Suspension
Zyclir
Zyma brand OF aciclovir
|
|
2 |
|
Docosanol |
Approved, Investigational |
Phase 4 |
|
30303-65-2, 661-19-8 |
12620
|
Synonyms:
169102_ALDRICH
1-Docosanol
1-DOCOSANOL
30303-65-2
4-01-00-01906 (Beilstein Handbook Reference)
43960_FLUKA
661-19-8
A3D72D45-625E-49B5-B0FC-394010B3485D
Abreva
Abreva (TN)
AC-19852
AC1L1ZZI
AC1Q2W4M
AC1Q7CQ8
AI3-36489
Behenic alcohol
Behenyl alcohol
BEHENYL ALCOHOL, 98%
Behenyl alcohol, Abreva, 1-Docosanol, Docosanol
Behenyl alcohol, AI3-36489, Behenic alcohol, 1-Docosanol, Docosyl alcohol, IK-2, Tadenan
BRN 1770470
C22H46O
CCRIS 8943
CHEBI:31000
CHEMBL1200453
CID12620
CPD-7845
D03884
D0964
DB00632
Debat
Doconsanol
docosan-1-ol
Docosan-1-ol
Docosanol
Docosanol (USAN)
|
Docosanol (VAN)
Docosanol [USAN]
Docosyl alcohol
EINECS 211-546-6
Erazaban
Healip
Herepair
HMS2093P22
HSDB 5739
IK 2
IK.2
InChI=1/C22H46O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23/h23H,2-22H2,1H
Lanette 22
Lidakol
Lidavol
LMFA05000008
LS-174295
LS-63381
MolPort-003-666-887
NAA 422
Nacol 22-97
NCGC00159370-02
NCGC00159370-03
n-Docosanol
N-Docosanol
NSC 8407
NSC8407
S1637_Selleck
SBB060170
Stenol 1822
Stenol 1822A
Tadenan
TL8004688
UNII-9G1OE216XY
V-1326
|
|
3 |
|
Ganciclovir |
Approved, Investigational |
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
82410-32-0 |
3454
|
Synonyms:
106931-35-5
107910-75-8 (mono-hydrochloride salt)
2-(6-amino-Purin-9-ylmethoxy)-propane-1,3-diol
2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol
2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one
2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-((1,3-Dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol
2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one
2-amino-9-(2-Hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one
2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-(2-Hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one
2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one
2'-NDG
2'-Nor-2'-deoxyguanosine
82410-32-0
86357-12-2
9-((1,3-Dihydroxy-2-propoxy)methyl)guanine
9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine
9-(1,3-DIHYDROXY-propoxymethane)guanine
9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE
9-[(1,3-dihydroxy-2-propoxy)methyl]guanine
9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine
96551-29-0
AC-12604
AC1L1FZ2
AC1Q52OB
AKOS004119898
BB_NC-1042
BIDD:GT0783
Biolf 62
BIOLF-62
BPBio1_000877
BSPBio_000797
BW 759
BW 759U
BW-759U
BW-795
BW-B 759U
CAS-82410-32-0
CCRIS 9212
CHEBI:465284
CHEMBL182
CID3454
Citovirax
CPD000058324
Cymevan
Cymeven
Cymevene
Cytovene
Cytovene (TN)
Cytovene-IV
D00333
DB01004
DRG-0018
EU-0100539
|
G 2536
G2536_SIGMA
GA2
ganciclovir
Ganciclovir
Ganciclovir & C34-dgA immunotoxin
Ganciclovir & D5-dgA immunotoxin
Ganciclovir (JAN/USP/INN)
Ganciclovir [USAN:INN:BAN:JAN]
Ganciclovir sodium
GANCICLOVIR SODIUM
Ganciclovir, monosodium salt
Ganciclovirum
Ganciclovirum [Latin]
Gancyclovir
GCV & 1110U81
GCV & MSL
Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)- and MSL, neutralizing monoclonal antibody
HHEMG
HMS1570H19
HMS2090K08
HSDB 6512
Hydroxyacyclovir
I07-0010
IN1478
Lopac0_000539
Lopac-G-2536
LS-73939
MB3795
MLS000028481
MLS001077349
MolPort-000-758-398
MolPort-002-507-301
NCGC00015471-01
NCGC00015471-02
NCGC00015471-03
NCGC00015471-06
NCGC00093928-01
NCGC00093928-02
NCGC00168567-01
nchembio.87-comp3
PDSP1_000816
PDSP2_000803
Prestwick_1068
Prestwick0_000839
Prestwick1_000839
Prestwick2_000839
Prestwick3_000839
RS-21592
SAM002548936
SMP2_000038
SMR000058324
SPBio_002718
ST-605
STK801910
UNII-P9G3CKZ4P5
Virgan
Vitrasert
Vitrasert (TN)
ZINC00001505
Zirgan
|
|
4 |
|
Methylprednisolone |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
83-43-2 |
6741
|
Synonyms:
(6a,11b)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6alpha,11beta)-11,17,21-Trihydroxy-6-methylpregna-1,4-diene-3,20-dione
(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-6,10,13-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one
(6α,11β)-11,17,21-trihydroxy-6-methylpregna-1,4-diene-3,20-dione
.DELTA.1-6.alpha.-Methylhydrocortisone
11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
11-beta,17,21-Trihydroxy-6-alpha-methylpregna-1,4-diene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methyl-1,4-pregnadiene-3,20-dione
11beta,17alpha,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione
121673-01-6
1-dehydro-6alpha-Methylhydrocortisone
1-Dehydro-6alpha-methylhydrocortisone
1-dehydro-6a-Methylhydrocortisone
1-dehydro-6α-methylhydrocortisone
4-08-00-03498 (Beilstein Handbook Reference)
46436_FLUKA
46436_RIEDEL
570-35-4
6 Methylprednisolone
6.alpha.-Methylprednisolone
6923-42-8
6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione
6alpha-methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methyl-11beta,17alpha,21-triol-1,4-pregnadiene-3,20-dione
6alpha-Methylprednisolone
6-alpha-Methylprednisolone
6a-Methyl-11b,17a,21-triol-1,4-pregnadiene-3,20-dione
6-Methylprednisolone
6α-methyl-11β,17α,21-triol-1,4-pregnadiene-3,20-dione
83-43-2
AC1L1N7A
Artisone-wyeth
Artisone-Wyeth
Besonia
Bio-0658
BPBio1_000174
BRD-K35240538-001-03-1
BRN 2340300
BSPBio_000158
CHEBI:6888
CHEMBL650
CID6741
CPD000058330
D00407
D008775
DB00959
delta(1)-6alpha-Methylhydrocortisone
Delta(1)-6alpha-Methylhydrocortisone
delta(1)-6a-Methylhydrocortisone
delta(sup 1)-6-alpha-Methylhydrocortisone
Depo-Medrol (acetate)
Dopomedrol
EINECS 201-476-4
Esametone
Firmacort
HMS1568H20
HMS2090B13
HSDB 3127
Lemod
LMST02030178
LS-118498
M0639_SIGMA
M1665
Medesone
Medixon
Medlone 21
Medrate
Medric acid
|
Medrol
Medrol (TN)
Medrol adt pak
Medrol Adt Pak
Medrol dosepak
Medrol Dosepak
Medrol, Solu-Medrol, Medrone, Methylprednisolone
Medrone
MEPRDL
Mesopren
Metastab
Methyleneprednisolone
Methylprednisolon
methylprednisolone
Methylprednisolone
Methylprednisolone (JP15/USP/INN)
Methylprednisolone [USAN:INN:BAN:JAN]
Methylprednisolone, 6-alpha
Methylprednisolonum
Methylprednisolonum [INN-Latin]
methylprenisolone
Metilbetasone
Metilprednisolona
Metilprednisolona [INN-Spanish]
Metilprednisolone
Metilprednisolone [Dcit]
Metilprednisolone [DCIT]
Metipred
Metrisone
Metrocort
Metysolon
MLS000028541
MLS001148159
MLS002207191
Moderin
MolPort-002-528-554
NCGC00022735-03
NCI60_001657
Nirypan
Noretona
NSC19987
NSC-19987
Predni N Tablinen
Prednol- L
Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl- (8CI)
Prestwick_622
Prestwick0_000279
Prestwick1_000279
Prestwick2_000279
Prestwick3_000279
Promacortine
Reactenol
S1733_Selleck
SAM002589984
Sieropresol
SMR000058330
Solomet
SPBio_002377
Summicort
Suprametil
U 7532
UNII-X4W7ZR7023
Urbason
Urbasone
Wyacort
ZINC03875560
δ(1)-6a-methylhydrocortisone
δ(1)-6α-methylhydrocortisone
|
|
5 |
|
Prednisolone |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
50-24-8 |
5755
|
Synonyms:
(11b)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione
(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione
.DELTA.1-Cortisol
.DELTA.1-Dehydrocortisol
.DELTA.1-Dehydrohydrocortisone
.DELTA.1-Hydrocortisone
.delta.-Cortef
.delta.-Stab
1,2-Dehydrohydrocortisone
1,4-Pregnadiene-11b,17a,21-triol-3,20-dione
1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione
1,4-pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-11β,17α,21-triol-3,20-dione
1,4-Pregnadiene-3,20-dione-11b,17a,21-triol
1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol
1,4-pregnadiene-3,20-dione-11β,17α,21-triol
1,4-Pregnadiene-3,20-dione-11β,17α,21-triol
1-Dehydrocortisol
1-Dehydrohydrocortisone
3,20-dioxo-11b,17a,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11beta,17alpha,21-Trihydroxy-1,4-pregnadiene
3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene
46656_FLUKA
46656_RIEDEL
50-24-8
58201-11-9
8056-11-9
AC-1773
AC1L1L2E
Ak-Pred
Ak-Tate
Alphadrol
Articulose-50
Bio-0666
BPBio1_000164
BRD-K98039984-001-03-0
BRN 1354103
BSPBio_000148
Bubbli-Pred
C07369
CCRIS 980
CHEBI:8378
CHEMBL131
CID5755
Codelcortone
Co-Hydeltra
CO-Hydeltra
component of Ataraxoid
component of K-Predne-Dome
Cordrol
Cortalone
Cotogesic
Cotolone
CPD000718761
D00472
D011239
DB00860
Decaprednil
Decortin H
Delcortol
Delta F
delta(1)-Cortisol
delta(1)-Dehydrocortisol
Delta(1)-Dehydrocortisol
delta(1)-Dehydrohydrocortisone
Delta(1)-dehydrohydrocortisone
Delta(1)-Dehydrohydrocortisone
delta(1)-Hydrocortisone
Delta(1)-Hydrocortisone
delta(sup 1)-Cortisol
delta(sup 1)-Dehydrocortisol
delta(sup 1)-Dehydrohydrocortisone
delta(sup 1)-Hydrocortisone
Delta-Cortef
Delta-Cortef (TN)
Deltacortenol
Deltacortril
Deltacortril Enteric
delta-dehydrocortisol
delta-dehydrohydrocortisone
Delta-Ef-Cortelan
delta-hydrocortisone
Deltahydrocortisone
Deltasolone
Delta-stab
Delta-Stab
Deltisilone
Depo-Medrol
Derpo Pd
Derpo PD
Dexa-Cortidelt hostacortin H
Dexa-Cortidelt Hostacortin H
Di adreson F
Di Adreson F
Di-adreson F
Di-Adreson F
Di-adreson-F
DiAdresonF
Di-Adreson-F
Dicortol
Donisolone
Dydeltrone
Eazolin D
Econopred
Econopred Plus
EINECS 200-021-7
Erbacort
Erbasona
Estilsona
Fernisolone
Fernisolone P
Fernisolone-P
Flamasone
HMS1568H10
HMS2090J05
Hostacortin H
HSDB 3385
Hydeltra
Hydeltrasol
Hydeltra-Tba
|
Hydeltrone
Hydrodeltalone
Hydrodeltisone
Hydroretrocortin
Hydroretrocortine
Inflamase Forte
Inflamase Mild
I-Pred
K 1557
Key-Pred
Klismacort
Lentosone
Lite Pred
LMST02030179
LS-7669
Medrol
Medrol Acetate
Metacortandralone
Methylprednisolone acetate
Methylprednisolone Acetate
Meticortelone
Meti-Derm
Metreton
MLS001304083
MLS002154250
MLS002207037
MolPort-002-507-147
M-Predrol
NCGC00179649-01
Neo-Delta-Cortef
Nisolone
Nor-Pred T.B.A.
NSC 9120
NSC9120
NSC9900
Ocu-Pred
Ocu-Pred Forte
Ophtho-Tate
Orapred
P0152_SIGMA
P0637
P6004_SIGMA
Panafcortelone
Paracortol
Paracotol
Pediapred
Poly-Pred
PRDL
Precortalon
Precortancyl
Precortilon
Precortisyl
Pred Forte
Pred Mild
Predair
Predair A
Predair Forte
Predalone 50
Predalone T.B.A.
Predate
Predate Tba
Predate-50
Predcor-25
Predcor-50
Predcor-Tba
PRED-G
Predisolone sodium phosphate
Predisolone Sodium Phosphate
Predne-Dome
Prednelan
Prednicen
Predni-Dome
Predniliderm
Predniretard
Prednis
Prednisolona
Prednisolona [INN-Spanish]
prednisolone
Prednisolone (anhydrous)
Prednisolone (JP15/USP/INN)
Prednisolone [INN:BAN:JAN]
Prednisolone acetate
Prednisolone Acetate
Prednisolone sodium phosphate
Prednisolone Sodium Phosphate
Prednisolone tebutate
Prednisolone Tebutate
Prednisolonum
Prednisolonum [INN-Latin]
Predonin
Predonine
Prelone
Prenolone
Prestwick_404
Prestwick0_000274
Prestwick1_000274
Prestwick2_000274
Prestwick3_000274
Rolisone
S1737_Selleck
SAM002264639
Scherisolon
SMR000718761
Solone
SPBio_002367
Steran
Sterane
Sterolone
Supercortisol
Ulacort
Ultra Pred
Ultracorten H
Ultracortene H
Ultracortene-H
Ultracortene-hydrogen
Ultracortene-Hydrogen
UNII-9PHQ9Y1OLM
ZINC03833821
δ(1)-dehydrocortisol
δ(1)-dehydrohydrocortisone
δ(1)-hydrocortisone
|
|
6 |
|
Prednisolone phosphate |
Approved, Vet_approved |
Phase 4,Phase 3 |
|
302-25-0 |
|
Synonyms:
Prednisolone 21-(dihydrogen phosphate)
Prednisolone 21-monophosphate
|
Prednisolone 21-phosphate
|
|
7 |
|
Methylprednisolone hemisuccinate |
Approved |
Phase 4,Phase 3 |
|
2921-57-5 |
|
Synonyms:
Methylprednisolone hydrogen succinate
|
Methylprednisolone succinate
|
|
8 |
|
Metronidazole |
Approved |
Phase 4 |
|
443-48-1 |
4173
|
Synonyms:
1-(2-hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxy-1-ethyl)-2-methyl-5-nitroimidazole
1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(2-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(beta-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(beta-Oxyethyl)-2-methyl-5-nitroimidazole
1-(b-Ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(b-Hydroxyethyl)-2-methyl-5-nitroimidazole
1-(b-Oxyethyl)-2-methyl-5-nitroimidazole
1-(β-ethylol)-2-methyl-5-nitro-3-azapyrrole
1-(β-hydroxyethyl)-2-methyl-5-nitroimidazole
1-(β-oxyethyl)-2-methyl-5-nitroimidazole
1-Hydroxyethyl-2-methyl-5-nitroimidazole
2 Methyl 5 nitroimidazole 1 ethanol
2-(2-methyl-5-nitroimidazol-1-yl)ethanol
2-methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-Methyl-1-(2-hydroxyethyl)-5-nitroimidazole
2-methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-3-(2-hydroxyethyl)-4-nitroimidazole
2-Methyl-5-nitro-1-imidazoleethanol
2-methyl-5-nitroimidazole-1-ethanol
2-Methyl-5-nitroimidazole-1-ethanol
443-48-1
46461_FLUKA
46461_RIEDEL
69198-10-3 (mono-hydrochloride)
99616-64-5
AB00052046
AC-10556
AC1L1HKS
AC1Q2P2Z
Acromona
AKOS000269646
Anagiardil
APMN
Apo-Metronidazole
Arilin
ARONIS24285
Atrivyl
BAS 02983617
BAY-5360
Bayer 5360
BCBcMAP01_000184
Bexon
BIDD:GT0107
Bio-0694
BPBio1_000004
BRD-K52020312-001-05-2
BRN 0611683
BSPBio_000002
BSPBio_002031
CAS-443-48-1
Caswell No. 579AA
CB-01-14 MMX
CCRIS 410
CHEBI:39845
CHEBI:6909
CHEMBL137
CID4173
Clont
CONT
CPD000058175
D00409
Danizol
DB00916
Deflamon
Deflamon-wirkstoff
DivK1c_000007
Efloran
EINECS 207-136-1
Elyzol
Entizol
EPA Pesticide Chemical Code 120401
Eumin
Flagemona
Flagesol
Flagil
Flagyl
Flagyl (TN)
Flagyl 375
Flagyl Er
Flagyl I.V.
Flagyl I.V. RTU
FLAGYL I.V. RTU IN PLASTIC CONTAINER
Flegyl
Florazole
Fossyol
Giatricol
Ginefla vir
Gineflavir
giniflavir
HMS1568A04
HMS1920N19
HMS2051G07
HMS2090B19
HMS2091F14
HMS500A09
HMS547C19
HSDB 3129
Hydrochloride, metronidazole
I14-0667
IDI1_000007
IDR-90105
KBio1_000007
KBio2_001515
KBio2_004083
KBio2_006651
KBio3_001531
KBioGR_000559
KBioSS_001515
Klion
Klont
LS-1264
M0924
M1547_SIGMA
M3761_FLUKA
M3761_SIGMA
M9036_SIGMA
Maybridge1_001999
Meronidal
Methronidazole
Methyl-5-nitroimidazole-1-ethanol
Metric
Metric 21
Metro Cream
Metro Gel
|
METRO I.V
Metro I.V.
Metro I.V. In Plastic Container
MetroCream
Metrodzhil
MetroGel
MetroGel-Vaginal
Metrogel-vaginal (TN)
Metrogyl
Metrolag
MetroLotion
Metrolyl
Metromidol
Metronidaz
Metronidazol
Metronidazol [INN-Spanish]
metronidazole
Metronidazole (JP15/USP/INN)
Metronidazole [USAN:INN:BAN:JAN]
Metronidazole benzoate
Metronidazole hydrochloride
Metronidazole in plastic container
Metronidazole in Plastic Container
Metronidazole monohydrochloride
Metronidazole Monohydrochloride
Metronidazole phosphate
Metronidazole phosphoester
Metronidazole Phosphoester
METRONIDAZOLE USP
Metronidazolo
Metronidazolo [DCIT]
Metronidazolum
Metronidazolum [INN-Latin]
Metrotop
Metrozine
Metryl
Mexibol
Mexibol 'silanes'
MLS000028590
MLS000758286
MolPort-000-141-892
MolPort-002-502-101
Monagyl
Monasin
Monohydrochloride, metronidazole
Nalox
NCGC00016446-01
NCGC00016446-02
NCGC00022059-03
NCGC00022059-04
NCGC00022059-05
NCIOpen2_000337
neo-Tric
NIDA
Nidagel
NINDS_000007
Noritate
Noritate (TN)
Novonidazol
NSC 50364
NSC 69587
NSC50364
NSC-50364
NSC69587
Orvagil
Phosphate, metronidazole
Phosphoester, metronidazole
Prestwick_334
Prestwick0_000081
Prestwick1_000081
Prestwick2_000081
Prestwick3_000081
Protostat
Rathimed
Rosased
RP 8823
RP-8823
S1907_Selleck
SAM001247010
Sanatrichom
Satric
SBB041018
SC 10295
SMP1_000189
SMR000058175
SPBio_000666
SPBio_001941
Spectrum_001035
SPECTRUM1500412
Spectrum2_000883
Spectrum3_000506
Spectrum4_000060
Spectrum5_001289
STK177359
Takimetol
Trichazol
Trichex
Tricho cordes
Trichocide
Tricho-gynaedron
Trichomol
Trichomonacid 'pharmachim'
Trichopal
Trichopol
Tricocet
Tricom
Tricowas B
Trikacide
Trikamon
Trikojol
Trikozol
Trimeks
Trivazol
UNII-140QMO216E
Vagilen
Vagimid
Vandazole
Vertisal
Wagitran
WLN: T5N CNJ A2Q B1 ENW
WLN: T5N CNJA2Q B1 ENW
WLN: T6NTJ DQ ANU1- ET5N CNJ A1 BNW
Zadstat
ZERO/004064
Zidoval
ZINC00113442
|
|
9 |
|
Dinoprost Tromethamine |
Approved, Vet_approved |
Phase 4 |
|
38562-01-5 |
5282415
|
Synonyms:
(5Z,9alpha,11alpha,13E,15S)-9,11,15-Trihydroxyprosta-5,13-dienoic acid tris salt
(E,Z)-(1R,2R,3R,5S)-7-(3,5-Dihydroxy-2-((3S)-(3-hydroxy-1-octenyl))cyclopentyl)-5-heptenoic acid compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid
1,3-Propanediol, 2-amino-2-(hydroxymethyl)-, (5Z,9alpha,11alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oate (salt)
2-amino-2-(hydroxymethyl)propane-1,3-diol
36300-07-9
38473-38-0
38562-01-5
51553-13-0
5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-, tham
7-(3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl)-5-heptenoic acid, tromethamine salt
AC1NR011
C20H34O5.C4H11NO3
CHEMBL1200896
CID5282415
D01352
DB01160
Dinolytic
Dinoprost trometamol
dinoprost tromethamine
Dinoprost tromethamine (JAN/USP)
Dinoprost tromethamine [USAN:JAN]
Dinoprost, trometamol salt
EINECS 254-002-3
Ensaprost
Enzaprost F compd. with trisamine
LS-125841
Lutalyse
Lutalyse (Veterinary)
MLS000028821
MolPort-003-939-186
NSC 196515
P0424_SIGMA
P5069_SIGMA
Panacelan F tromethamine salt
|
PGF2-alpha tham
PGF2alpha THAM
PGF2-alpha THAM
PGF2-alpha tris salt
PGF2alpha tromethamine
PGF2-alpha tromethamine
PGF2-alpha tromethamine salt
PGF2alpha-Tris
Pronalgon F
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-, compd. with trimethylolaminomethane
Prosta-5,13-dien-1-oic acid, (5Z,9-alpha,11-alpha,13E,15S)-9,11,15-trihydroxy-,compd. with trimethylolaminomethane
Prosta-5,13-dien-1-oic acid, 9,11,15-trihydroxy-, (5Z,9alpha,11alpha,13E,15S)-, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)
Prostaglandin F(sub 2a) tromethamine
Prostaglandin F2a tromethamine
Prostaglandin F2alpha tham
Prostaglandin F2-alpha THAM
Prostaglandin F2-alpha THAM salt
PROSTAGLANDIN F2ALPHA TRIS SALT
prostaglandin F2alpha tromethamine
Prostaglandin F2-alpha tromethamine
Prostaglandin F-2alpha tromethamine salt
Prostalmon F
Prostamate
Prostin F2 alpha
Prostin F2 Alpha
Prostin F2 alpha (TN)
Protaglandin F2-alpha-tham salt
SMR000058792
THAM PGF2-alpha
Tromethamine prostaglandin F2-alpha
U 14585
U-14,583E
U-14583E
UNII-CT6BBQ5A68
Zinoprost
|
|
10 |
|
Bimatoprost |
Approved, Investigational |
Phase 4 |
|
155206-00-1 |
5311027
|
Synonyms:
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1e,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
155206-00-1
15M
267244-98-4
5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)
AC1NSJUW
AGN 192024
AGN-192024
Bimataprost [USAN:INN:BAN]
bimatoprost
Bimatoprost
Bimatoprost (JAN/USAN/INN)
Bimatoprost [USAN:INN:BAN]
bimatoprostum
|
Bimatoprostum
CHEBI:39562
CHEBI:51230
CHEMBL1200963
CID5311027
D02724
DB00905
DB06863
I06-1275
I06-1277
Latisse
LS-181817
Lumigan
Lumigan (TN)
NCGC00181745-01
UNII-QXS94885MZ
ZINC04474405
|
|
11 |
|
Dinoprost |
Approved, Investigational |
Phase 4 |
|
551-11-1 |
5283078
|
Synonyms:
(+)-Prostaglandin F2a
(5Z,13E)-(15S)-9-alpha,11-alpha,15-Trihydroxyprosta-5,13-dienoate
(5Z,13E)-(15S)-9-alpha,11-alpha,15-Trihydroxyprosta-5,13-dienoic acid
(5Z,13E,15S)-9a,11a,15-Trihydroxyprosta-5,13-dien-1-Oate
(5Z,13E,15S)-9a,11a,15-Trihydroxyprosta-5,13-dien-1-Oic acid
(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxy-prosta-5,13-dien-1-Oate
(5Z,9a,11a,13E,15S)-9,11,15-Trihydroxy-prosta-5,13-dien-1-Oic acid
(9alpha,11alpha,15)-Trihydroxyprosta-(5Z,13E)-dien-1-Oate
(9alpha,11alpha,15)-Trihydroxyprosta-(5Z,13E)-dien-1-Oic acid
7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoate
7-[3,5-Dihydroxy-2-(3-hydroxy-1-octenyl)cyclopentyl]-5-heptenoic acid
9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-Oate
9,11,15-Trihydroxy-(5Z,9a,11a,13E,15S)-prosta-5,13-dien-1-Oic acid
9,11,15-Trihydroxyprosta-5Z,13E-dien-1-Oate
9,11,15-Trihydroxyprosta-5Z,13E-dien-1-Oic acid
9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoate
9a,11a,15(S)-Trihydroxy-5-cis-13-trans-prostadienoic acid
9a,11a-PGF2
9a,11a-PGF2a
9alpha,11beta PGF2
9alpha,11beta-PGF2
alpha, PGF2
Amoglandin
Cyclosin
|
Dinifertin
Dinoprost
dinoprosta
Enzaprost
Enzaprost F
Estrofan
F2 alpha, Prostaglandin
F2a Isoprostane
F2alpha, Prostaglandin
Glandin N
L-PGF2-alpha
L-Prostaglandin F2-alpha
Panacelan
PGF2
PGF2 alpha
PGF2a
PGF2alpha
Prostaglandin F2
Prostaglandin F2 alpha
Prostaglandin F2alpha
Prostamate
Prostarmon F
Prostin F 2 alpha
Protamodin
|
|
12 |
|
Mycophenolic acid |
Approved |
Phase 4,Phase 3 |
|
24280-93-1 |
446541
|
Synonyms:
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoate
(e)-6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-5-phthalanyl)-4-methyl-4-hexenoic acid
Acid, mycophenolic
Acide mycophenolique
acido Micofenolico
Acido micofenolico
Acidum mycophenolicum
Melbex
|
micofenolico acido
Micofenolico acido
Mycophenoic acid
Mycophenolate
Mycophenolsaeure
Mycophenolsäure
Myfortic
|
|
13 |
|
Miconazole |
Approved, Investigational, Vet_approved |
Phase 4,Early Phase 1 |
|
22916-47-8 |
4189
|
Synonyms:
(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole
1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole
1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole
1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole
1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole
1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole
1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole
1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
22832-87-7 (NITRATE)
22916-47-8
75319-47-0
AB00053500
AC1L1HM1
Aflorix(nitrate)
AKOS001574474
Albistat(nitrate)
Andergin(nitrate)
BPBio1_000279
BRD-A82396632-001-03-0
BRD-A82396632-008-02-7
Brentan
BRN 0965511
BSPBio_000253
BSPBio_002033
CCRIS 7924
CHEBI:6923
CHEMBL91
CID4189
Conofite(nitrate)
CPD-4501
D00416
Dactarin
Daktarin iv
Daktarin IV
DB01110
DivK1c_000156
EINECS 245-324-5
Epi-Monistat(nitrate)
Esteve brand OF miconazole
Femizol-M
Florid(nitrate)
Gyno-Daktar(nitrate)
HMS1568M15
HMS2090B21
I14-14342
IDI1_000156
imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)
Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)
Janssen cilag brand OF miconazole
Janssen-cilag brand OF miconazole
Johnston and johnston brand OF miconazole nitrate
KBio1_000156
KBio2_001445
KBio2_004013
KBio2_006581
KBio3_001533
KBioGR_000581
KBioSS_001445
Lotrimin AF(nitrate)
LS-78378
MCZ
Micantin (nitrate)
Miconasil nitrate
Miconasil Nitrate
Miconazol
|
Miconazol [INN-Spanish]
miconazole
Miconazole
Miconazole (JP15/USP/INN)
Miconazole [USAN:BAN:INN:JAN]
Miconazole 3
Miconazole 3 Combination Pack
Miconazole 7 Combination Pack
Miconazole esteve brand
Miconazole janssen-cilag brand
Miconazole nitrate
Miconazole nitrate salt
Miconazole-7
Miconazolo
Miconazolo [DCIT]
Miconazolum
Miconazolum [INN-Latin]
Micozole
Minostate
MJR 1762
MLS002222203
MolPort-002-557-553
Monazole 7
Monista (nitrate)
Monistat
Monistat (TN)
Monistat 1 Combination Pack
Monistat 3 Dual-Pak
Monistat 3 Vaginal Ovules
Monistat 5 Tampon
Monistat 7 Dual-Pak
Monistat 7 Vaginal Suppositories
Monistat Dual- PAK
Monistat IV
Monistat iv (tn)
Monistat iv (TN)
Monistat-Derm
NCI60_001353
NCI60_001380
NINDS_000156
Nitrate, miconasil
Nitrate, miconazole
Novo-Miconazole Vaginal Ovules
NSC 170986
NSC169434
NSC170986
Oprea1_091955
Prestwick_335
Prestwick0_000067
Prestwick1_000067
Prestwick2_000067
Prestwick3_000067
R 18134
R-14,889
SMR001307249
SPBio_000976
SPBio_002174
Spectrum_000965
Spectrum2_001048
Spectrum3_000507
Spectrum4_000061
Spectrum5_001297
STK834405
STOCK1S-93556
UNII-7NNO0D7S5M
Vusion
Zimycan
|
|
14 |
|
Ritonavir |
Approved, Investigational |
Phase 4,Phase 3 |
|
155213-67-5 |
392622
|
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
538, ABT
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
A-84538
Abbott 84538
ABBOTT-84538
ABT 538
ABT 84538
ABT538
ABT-538
AC1L94GB
AC-733
AKOS000280930
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
DB00503
|
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
NSC693184
RIT
ritonavir
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
RTV
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
|
|
15 |
|
Emtricitabine |
Approved, Investigational |
Phase 4,Not Applicable |
|
143491-57-0 |
60877
|
Synonyms:
(-)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(−)-(2R,5S)-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-(2R,5S)-5-fluoro-1-[2-(Hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
(-)-.beta.-L-FTC
(-)-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(−)-2'-deoxy-5-fluoro-3'-thiacytidine
(-)-2'-Deoxy-5-fluoro-3'-thiacytidine
(-)-b-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(-)-beta-2',3'-Dideoxy-5-fluoro-3'-thiacytidine
(-)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(−)-cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-cis-4-amino-5-fluoro-1-(2-Hydroxymethyl-1,3-oxathiolan-5-yl)-(1H)-pyrimidin-2-one
(-)-FTC
(−)-FTC
(-)-β-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(−)-β-2',3'-dideoxy-5-fluoro-3'-thiacytidine
(2R-cis)-4-amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-amino-5-fluoro-1-(2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
(2R-cis)-4-Amino-5-fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-2(1H)-pyrimidinone
.beta.-L-(-)-(2R,5S)-5-Fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine
1-(2-(Hydroxymethyl)oxathiolan-5-yl)-5-fluorocytosine
143491-54-7
143491-57-0
145213-48-5
2',3',5-FTC
2',3'-Dideoxy-5-fluoro-3'-thiacytidine
2'-Deoxy-5-fluoro-3'-oxa-4'-thiocytidine
2'-Deoxy-5-fluoro-3'-thiacytidine
2-FTC
3'-Thia-2'.3'-dideoxy-5-fluorocytidine
4-amino-5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)pyrimidin-2(1H)-one
4-amino-5-fluoro-1-((2R,5S)-2-Hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-((2R,5S)-2-hydroxymethyl-[1,3]oxathiolan-5-yl)-1H-pyrimidin-2-one
4-Amino-5-fluoro-1-[(2R,5S)-(hydroxymethyl)-1,3-oxathiolan-5-yl]-2(1H)-pyrimidinone
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2(1H)-one
4-amino-5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one
524W91
5-fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-((2R,5S)-2-(Hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-Fluoro-1-((2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
|
5-Fluoro-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)cytosine
5-fluoro-1-[(2R,5S)-2-(hydroxymethyl)[1,3]oxathiolan-5-yl]cytosine
AC1L1U3I
AC1Q4KUB
beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine
BW 1592
BW 524W91
BW524W91
BW-524W91
C122114
C12599
C8H10FN3O3S
CHEBI:31536
CHEMBL885
CID60877
Coviracil
Coviracil(TM)
D01199
DB00879
dOTFC
DRG-0208
Emtricitabin
Emtricitabina
Emtricitabine
Emtricitabine (JAN/USAN/INN)
Emtricitabinum
Emtriva
Emtriva (TN)
Emtriva(TM)
FT-0080009
HMS2089I05
HSDB 7337
LS-135838
LS-173184
NCGC00164564-01
Racivir
RCV
SBB066061
TL8000958
UNII-G70B4ETF4S
ZINC03629271
|
|
16 |
|
Nevirapine |
Approved |
Phase 4 |
|
129618-40-2 |
4463
|
Synonyms:
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)
11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one
11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one
11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE
129618-40-2
1vrt
2hny
AC1L1I81
AC-643
BI RG 587
BIDD:GT0326
Bio-0789
BIRG 0587
BIRG 587
BIRG-0587
BIRG587
BIRG-587
BI-RG-587
BI-RG-587 & CD4-IgG
C07263
C15H14N4O
Cahill May Roberts Brand of Nevirapine
CHEBI:44659
CHEMBL57
CID4463
CPD000048458
D00435
D019829
DB00238
DB08311
Hemihydrate, nevirapine
HMS2051J09
|
HSDB 7164
I02-0310
LS-2289
MLS000084585
MLS000759409
MLS001055309
MLS001201730
MolPort-002-507-817
N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin
NCGC00065890-02
NEV
nevirapine
Nevirapine & CD4-IgG
Nevirapine & PRO 140
Nevirapine (JAN/USP/INN)
Nevirapine [USAN:INN]
Nevirapine anhydrous
Nevirapine hemihydrate
Nevirapine, anhydrous
NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE
NSC 641530
NSC641530
NVP
Promeco Brand of Nevirapine
S1742_Selleck
SAM001246551
SMR000048458
STK580320
UNII-99DK7FVK1H
Viramune
Viramune (TN)
Viramune(TM)
Viramune, BI-RG 587, Nevirapine
ZINC00004778
|
|
17 |
|
Penciclovir |
Approved |
Phase 4,Phase 3 |
|
39809-25-1 |
4725
|
Synonyms:
2-Amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)butyl]-6H-purin-6-one
2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-1,9-dihydro-6H-purin-6-one
2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3,9-dihydropurin-6-one
2-amino-9-[4-hydroxy-3-(hydroxymethyl)butyl]-3H-purin-6-one
39809-25-1
6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- & Human interferon-.alpha.
6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- & Human interferon-.gamma.
6H-Purin-6-one, 2-amino-1,9-dihydro-9-(4-hydroxy-3-(hydroxymethyl)butyl)- & Human interferon-beta
9-(4-HYDROXY-3-(HYDROXYMETHYL)BUT-1-YL)GUANINE
9-(4-hydroxy-3-(hydroxymethyl)butyl)guanine
9-(4-Hydroxy-3-(hydroxymethyl)butyl)guanine
9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine
9-(4-hydroxy-3-hydroxymethylbut-1-yl)-guanine
9-(4-Hydroxy-3-hydroxymethylbut-1-yl)guanine
9-(4-Hydroxy-3-hydroxymethylbut-1-yl)-guanine
9-[2-hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine
9-[2-Hydroxy-1-(hydroxymethyl)-ethoxymethyl]guanine
9-[4-hydroxy-3-(hydroxymethyl)but-1-yl]guanine
9-[4-Hydroxy-3-(hydroxymethyl)but-1-yl]guanine
97845-62-0 (mono-hydrochloride salt)
AC-11104
AC1L1ITE
Adenovir
BRL 39123
BRL-39123
C07417
C10H15N5O3
CCRIS 9213
CHEBI:44870
CHEBI:530597
CHEBI:7956
CHEMBL1540
CID4725
CPD000466317
D05407
DB00299
|
DB01730
Denavir
Denavir (TN)
FT-0080010
HMS2051D06
HMS2090H11
I14-2420
IN1162
LS-127198
MB2488
MLS000759422
MLS001424110
NCGC00164630-01
Novartis brand OF penciclovir
PCV
PE2
penciclovir
Penciclovir & Human interferon-.alpha.
Penciclovir & Human interferon-.beta.
Penciclovir & Human interferon-.gamma.
Penciclovir (USAN/INN)
Penciclovir [USAN:INN:BAN]
Penciclovir visfarm
Penciclovir, monosodium salt
Penciclovir, monosodium salt, monohydrate
Penciclovirum
Penciclovirum [INN-Latin]
Pencyclovir
SAM001246580
SBB067261
SB-CH Brand OF penciclovir
SMR000466317
UNII-359HUE8FJC
Vectavir
Visfarm brand OF penciclovir
ZINC00001899
|
|
18 |
|
Famciclovir |
Approved, Investigational |
Phase 4,Phase 3,Phase 2 |
|
104227-87-4 |
3324
|
Synonyms:
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)
104227-87-4
2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester)
2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetic acid
2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate
9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine
9-(4-Acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
AC-11064
AC1L1FOB
Acetate 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
Anti-Farnesyl Rabbit pAb
Bio-0039
BRD-K45033733-001-02-3
BRL 42810
BRL-42810
BSPBio_003489
C14H19N5O4
CHEBI:4974
CHEMBL880
CID3324
CPD000466375
D00317
DB00426
Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine
famciclovir
Famciclovir
Famciclovir (JAN/USAN/INN)
Famciclovir [USAN:BAN:INN]
Famciclovirum
|
Famciclovirum [INN-Latin]
Famvir
Famvir (TN)
FCV
HMS1922L09
HMS2051G22
HMS2090G10
HMS2093K12
I03-0096
IN1338
KBio2_000946
KBio2_003514
KBio2_006082
KBio3_002709
KBioGR_001162
KBioSS_000946
LS-120147
MLS000759505
MLS001424115
MolPort-003-666-602
NCGC00095133-01
NCGC00095133-02
NCGC00095133-03
Oravir
S2467_Selleck
SAM001246732
SMR000466375
SPBio_001202
Spectrum_000466
SPECTRUM1505201
Spectrum2_001101
Spectrum3_001675
Spectrum4_000611
Spectrum5_001548
STK623204
UNII-QIC03ANI02
ZINC01530635
|
|
19 |
|
Difluprednate |
Approved |
Phase 4 |
|
23674-86-4 |
443936
|
Synonyms:
DFBA
Difluoroprednisolone butyrate acetate
Difluprednic acid
|
|
|
20 |
|
Prednisolone hemisuccinate |
Experimental |
Phase 4,Phase 3 |
|
2920-86-7 |
|
Synonyms:
(+)-prednisolone hemisuccinate
Prednisolonbisuccinat
Prednisolone 21-hemisuccinate
Prednisolone 21-succinate
|
Prednisolone bisuccinate
Prednisolone hydrogen succinate
Prednisolone succinate
|
|
21 |
|
Tenofovir |
Experimental, Investigational |
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
147127-20-6 |
464205
|
Synonyms:
(R)-9-(2-Phosphonomethoxypropyl)adenine
(R)-9-(2-Phosphonylmethoxypropyl)adenine
(R)-PMPA
[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid
147127-20-6
206184-49-8
9-(2-Phosphonomethoxypropyl)adenine
9-(2-Phosphonylmethoxypropyl)adenine
9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer
9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098
9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer
9-PMPA (tenofovir)
AC1LA9BO
AC-760
Anh. tenofovir
Anhydrous tenofovir
Apropovir
CHEBI:45809
CHEMBL483
CID464205
D,L-Tenofovir
DB00300
Disoproxil fumarate, tenofovir
Disoproxil, tenofovir
Fumarate, tenofovir disoproxil
GNA & Tenofovir
|
GS 1275
GS 1278
GS1278
HHA & Tenofovir
KS-5021
MolPort-003-850-411
NCGC00167535-01
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)
Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- (9CI)
Phosphonic acid, [[2-(6-amino-9H-purin-9
PMPA
PMPA-(R)
S1401_Selleck
TDF
Tenefovir
Tenofovir
Tenofovir (anh.)
Tenofovir (anhydrous)
Tenofovir anhydrous
Tenofovir disoproxil
Tenofovir disoproxil fumarate
TFV
UNII-99YXE507IL
Viread
Viread, Tenofovir
|
|
22 |
|
Anti-Infective Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
23 |
|
Antiviral Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
24 |
|
Nucleic Acid Synthesis Inhibitors |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
25 |
|
Ganciclovir triphosphate |
|
Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable |
|
|
|
26 |
|
Antiparasitic Agents |
|
Phase 4,Phase 2 |
|
|
|
27 |
|
Antiprotozoal Agents |
|
Phase 4,Phase 2 |
|
|
|
28 |
|
valacyclovir |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
29 |
|
Ophthalmic Solutions |
|
Phase 4 |
|
|
|
30 |
|
Hormones, Hormone Substitutes, and Hormone Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
31 |
|
Immunologic Factors |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
32 |
|
Protective Agents |
|
Phase 4,Phase 3,Phase 2 |
|
|
|
33 |
|
Autonomic Agents |
|
Phase 4,Phase 3,Phase 1 |
|
|
|
34 |
|
Hormone Antagonists |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
35 |
|
Antirheumatic Agents |
|
Phase 4,Phase 1 |
|
|
|
36 |
|
Gastrointestinal Agents |
|
Phase 4,Phase 3,Phase 1 |
|
|
|
37 |
|
Anti-Inflammatory Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
38 |
|
Peripheral Nervous System Agents |
|
Phase 4,Phase 3,Phase 1,Not Applicable |
|
|
|
39 |
|
Dermatologic Agents |
|
Phase 4,Phase 2,Not Applicable,Early Phase 1 |
|
|
|
40 |
|
Prednisolone acetate |
|
Phase 4,Phase 3 |
|
|
|
41 |
|
Hormones |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
42 |
|
Immunoglobulin G |
|
Phase 4,Phase 2,Phase 1 |
|
|
|
43 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
44 |
|
Methylprednisolone acetate |
|
Phase 4,Phase 3 |
|
|
|
45 |
|
Anti-Bacterial Agents |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 |
|
|
|
46 |
|
glucocorticoids |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
47 |
|
Antibodies |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
48 |
|
Immunoglobulins |
|
Phase 4,Phase 2,Phase 1,Not Applicable |
|
|
|
49 |
|
Neuroprotective Agents |
|
Phase 4,Phase 3 |
|
|
|
50 |
|
Reverse Transcriptase Inhibitors |
|
Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 316)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis) |
Unknown status |
NCT00467662
|
Phase 4 |
Acyclovir 5%;Docosanol 10% |
2 |
PTH - Preemptive Treatment for Herpesviridae |
Unknown status |
NCT02152358
|
Phase 4 |
Aciclovir;Ganciclovir;Placebo |
3 |
Effect of HSV-2 Suppressive Therapy on Sexual Behavior |
Unknown status |
NCT00495716
|
Phase 4 |
acyclovir;acyclovir |
4 |
Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding |
Completed |
NCT01448616
|
Phase 4 |
TDF;Placebo Vaginal Gel;Vaginal TFV Gel;Placebo Tablets |
5 |
Asymptomatic Bacterial Vaginosis and Herpes Simplex Virus Type 2 (BV/HSV-2) Shedding Study |
Completed |
NCT00464542
|
Phase 4 |
Metronidazole |
6 |
Palatability Testing of a New Paediatric Formulation of Valacyclovir |
Completed |
NCT01682109
|
Phase 4 |
Valacyclovir |
7 |
A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies. |
Completed |
NCT00158860
|
Phase 4 |
valaciclovir (VALTREX®) |
8 |
Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV |
Completed |
NCT00527618
|
Phase 4 |
valacyclovir;acyclovir |
9 |
Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia |
Completed |
NCT01794897
|
Phase 4 |
Experimental: Valacyclovir treatment;Placebo comparator |
10 |
A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected Persons |
Completed |
NCT00161434
|
Phase 4 |
valacyclovir;placebo |
11 |
Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 |
Completed |
NCT01346475
|
Phase 4 |
valacyclovir;Valacyclovir |
12 |
A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation |
Completed |
NCT00723229
|
Phase 4 |
acyclovir |
13 |
Randomized Trial to Evaluate Suppressive Effect of High-Dose Acyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 |
Completed |
NCT00362297
|
Phase 4 |
acyclovir;valacyclovir |
14 |
VALTREX Once Daily For Viral Shedding In Herpes Simplex Virus 2 (HSV-2) Seropositive Subjects. VALTREX® Tablet is a Trademark of GlaxoSmithKline Group of Companies. |
Completed |
NCT00116844
|
Phase 4 |
Valaciclovir;Placebo |
15 |
Valacyclovir vs. Acyclovir as HSV-2 Suppressive Therapy: Effect on Plasma HIV-1 Levels Among HIV-1/HSV-2 Co-infected Persons |
Completed |
NCT01026454
|
Phase 4 |
acyclovir;valacyclovir |
16 |
VALTREX(Valacyclovir) Once Daily for Viral Shedding In Subjects Newly Diagnosed With HSV-2 |
Completed |
NCT00306293
|
Phase 4 |
valacyclovir |
17 |
A Randomized Controlled Trial of Acyclovir Among HIV and HSV-2 Co-Infected Women, Chiang Rai, Thailand |
Completed |
NCT00362596
|
Phase 4 |
acyclovir |
18 |
Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) |
Completed |
NCT02059655
|
Phase 4 |
Bimatoprost;Eye drop solution |
19 |
A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac Transplantation |
Completed |
NCT00048165
|
Phase 4 |
Daclizumab;Methylprednisolone;Mycophenolate mofetil;Placebo;cyclosporine |
20 |
Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) |
Completed |
NCT00552240
|
Phase 4 |
tenofovir DF 300 mg QD;tenofovir DF 300 mg QD;emtricitabine 200 mg QD;emtricitabine 200 mg QD;Nevirapine 200 mg BID;Atazanavir 300 mg;Ritonavir 100 mg |
21 |
A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers |
Completed |
NCT00820534
|
Phase 4 |
Penciclovir;Placebo |
22 |
Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients |
Completed |
NCT00477334
|
Phase 4 |
Famciclovir;Placebo |
23 |
A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes Labialis |
Completed |
NCT00248144
|
Phase 4 |
Famciclovir |
24 |
RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With Famciclovir |
Completed |
NCT00219310
|
Phase 4 |
Famciclovir |
25 |
A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding |
Completed |
NCT00129818
|
Phase 4 |
Famciclovir |
26 |
A Randomized Trial of Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis |
Not yet recruiting |
NCT03626376
|
Phase 4 |
oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily;oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops |
27 |
The Flocked Swab and the Traditional Fiber Swab for the Diagnosis of the Herpes Simplex Epithelial Keratitis |
Terminated |
NCT02045082
|
Phase 4 |
|
28 |
A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected Persons |
Terminated |
NCT00079911
|
Phase 4 |
valacyclovir hydrochloride |
29 |
A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected Patients |
Unknown status |
NCT00005663
|
Phase 3 |
Valacyclovir hydrochloride |
30 |
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous System |
Unknown status |
NCT00006132
|
Phase 3 |
acyclovir |
31 |
Herpetic Eye Disease Study (HEDS) I |
Unknown status |
NCT00000138
|
Phase 3 |
Prednisolone Phosphate;Acyclovir |
32 |
Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community |
Unknown status |
NCT00124878
|
Phase 3 |
|
33 |
NB-001 Treatment of Recurrent Herpes Labialis |
Unknown status |
NCT01695187
|
Phase 3 |
NB-001 (0.3%);Placebo |
34 |
Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease |
Completed |
NCT00699764
|
Phase 3 |
|
35 |
Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative Subjects |
Completed |
NCT00698568
|
Phase 3 |
|
36 |
Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old |
Completed |
NCT00224484
|
Phase 3 |
|
37 |
Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth |
Completed |
NCT00031447
|
Phase 3 |
Acyclovir;Placebo |
38 |
Open-label Study of ASP2151 in Herpes Simplex Patients |
Completed |
NCT02209324
|
Phase 3 |
ASP2151 |
39 |
Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex Vaccine |
Completed |
NCT00224471
|
Phase 3 |
|
40 |
Phase III Study of ASP2151 in Herpes Simplex Patients |
Completed |
NCT01959295
|
Phase 3 |
ASP2151;ASP2151 placebo |
41 |
Valaciclovir Hydrochloride Phase III for Hematopoietic Stem Cell Transplantation Patients |
Completed |
NCT01602562
|
Phase 3 |
VACV tablets (Adults or pediatrics) or granules (pediatrics) |
42 |
Acyclovir in Preventing Herpes Simplex Virus Infection in Patients With Neutropenia |
Completed |
NCT00855309
|
Phase 3 |
acyclovir sodium |
43 |
Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates |
Completed |
NCT00031460
|
Phase 3 |
Acyclovir;Placebo |
44 |
Valaciclovir to Prevent Transmission of Herpes Simplex Virus |
Completed |
NCT00001649
|
Phase 3 |
Valaciclovir |
45 |
Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection |
Completed |
NCT00098059
|
Phase 3 |
Famciclovir |
46 |
Zinc for the Treatment of Herpes Simplex Labialis (HSL) |
Completed |
NCT00809809
|
Phase 3 |
Zicam (Ionic zinc);placebo |
47 |
Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir |
Completed |
NCT00031486
|
Phase 3 |
Valacyclovir;Placebo |
48 |
HerpeVac Trial for Young Women |
Completed |
NCT00057330
|
Phase 3 |
|
49 |
Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth |
Completed |
NCT00006135
|
Phase 3 |
acyclovir |
50 |
Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth |
Completed |
NCT00004757
|
Phase 3 |
acyclovir |
Inferred drug relations via
UMLS
73
/
NDF-RT
51
:
Cochrane evidence based reviews: herpes simplex
|